CIHR HIV/AIDS Research Initiative: Strategic plan (2015-2020) – Long Descriptions

Figure 1: CIHR Investments in HIV/AIDS Research – 2004-05 to 2013-14

2004-05 2005-06 2006-07 2007-08 2008-09 2009-10 2010-11 2011-12 2012-13 2013-14
HIV-AIDS Initiative $15,997,331 $16,163,840 $16,691,236 $17,338,558 $19,271,158 $21,417,273 $23,649,537 $22,777,072 $23,495,329 $23,852,800
Other CIHR Investments $19,160,508 $21,130,859 $22,061,576 $20,909,185 $21,641,138 $21,612,496 $22,462,007 $23,443,052 $23,521,593 $24,631,199
Total CIHR expenditures (HIV-AIDS) $35,157,839 $37,294,700 $38,752,812 $38,247,743 $40,912,295 $43,029,770 $46,111,544 $46,220,124 $47,016,922 $48,483,999

« Back to figure 1

Figure 2: CIHR Investments in HIV/AIDS Research by Research Theme – 2004-05 and 2013-14

Primary Theme 2004-05 2013-14
Biomedical $9,228,147 $14,724,968
Clinical $5,576,743 $8,635,294
Health systems/services $295,760 $4,082,030
Social/cultural/environmental/population health $5,704,542 $13,551,296
Not specified $2,520,491 $2,454,333
Total $23,325,683 $43,447,921

« Back to figure 2

Date modified: